跳至主要内容
临床试验/NCT06965803
NCT06965803招募中不适用

Continuous Glucose Monitor (CGM) Discharge Program

Cedars-Sinai Medical Center1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2025年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
37
试验地点
1
主要终点
Patient Satisfaction (using a 5-point likert scale)

研究概览

简要总结

The purpose of the study is to improve patient-reported outcomes by improving patient's satisfaction and quality of life (QOL) with glucose monitoring device through pre and post satisfaction survey of patient with diabetes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •aged 18 or older
  • •diagnosed with Type 1 or Type 2 Diabetes who are on insulin
  • •able to speak and understand English language
  • •scheduled to receive a standard inpatient diabetes education consultation
  • •must not have used CGM in the six months prior to admission
  • •owns a smartphone
  • •demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program

排除标准

  • •those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices.
  • •non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.

结局指标

主要结局

Patient Satisfaction (using a 5-point likert scale)

时间窗: 15 days

Glucose Monitoring Satisfaction Survey

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew Monterola

Associate Director, Clinical Support Programs

Cedars-Sinai Medical Center

研究点 (1)

Loading locations...

相似试验